<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00880607</url>
  </required_header>
  <id_info>
    <org_study_id>08-0721</org_study_id>
    <secondary_id>Seed grant UCHSC</secondary_id>
    <nct_id>NCT00880607</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion</brief_title>
  <official_title>The Use of Intraoperative Intrathecal Morphine Versus Epidural Extended Release Morphine for Postoperative Pain Control in Pediatric Patients Undergoing Posterior Spinal Fusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about preventing pain in children who are having posterior
      spinal fusion surgery using two different kinds of morphine (a pain medicine). Also, this
      study plans to learn about individual differences in the how the different kinds of morphine
      work in children.

      Subjects are being asked to be in this research study because they are having spinal fusion
      surgery, will have pain some of the time and will be getting morphine during and after
      surgery to help control their pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 80 people from Denver will participate in the study. Subjects will be randomized to
      receive one of two possible medications during surgery to help with pain after surgery. After
      they go to sleep for surgery the anesthesiologist will give them either (1) a single
      injection of morphine into the spinal fluid in the lower back, or (2) a single injection of
      extended-release morphine into the epidural space (just outside the spinal fluid) in the
      lower back.

      The usual care for patients having this surgery is a single injection of morphine into the
      spinal fluid in the lower back. If randomized to group (1), subjects will receive the usual
      care for pain control. If subjects are randomized to group (2), they will receive a single
      injection of extended-release morphine into the epidural space.

      During surgery, a small blood sample (1 teaspoon or less) will be collected to analyze
      specific DNA sequences that are involved in individual responses to morphine for pain
      control. The blood sample will be destroyed after 24 months.

      After surgery, subjects will have IV pain medication through a patient-controlled analgesia
      (PCA) machine. Subjects will be shown how to work the PCA so they can get the pain medicine
      when they need it. A research nurse will check in frequently to ask how much pain is
      occurring following the surgery and any side effects that may arise from the study medicine.

      Subjects will be in this study up to 60 hours after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total IV Morphine Consumption up to 48 Hours Post Surgery</measure>
    <time_frame>Four hour intervals for up to 48 hours</time_frame>
    <description>Total IV morphine consumption during the first 0- 48 hours after surgery.Postoperative pain was treated with morphine PCA, ketorolac, oral oxycodone, and acetaminophen.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time Until First PCA Demand Request</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>At 4-hour intervals for up to 48 hours IV PCA demands.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain Scores</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>Post-operative pain scores using Bieri faces scale every 4 hours up to 48 hours. Using Bieri faces pain scale. The faces show how much something can hurt. The &quot;happy face&quot; with a smile is no pain = 0 to faces showing more and more pain up 10. The space between two faces is scored 1, 3,5,7, or 9. to 10 (worst pain) will be used every 4 hours post-op for up to 48 hours.
*Scores were not collected and/or included for all participants at all time points. If a patient was sleeping, there score was not recorded. If a patient completed the pain scale incorrectly (used an even number or included a range), then the data point was not included.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Opioid Effect: Nausea</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>presence of nausea- dichotomous variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Opioid Effect: Emesis</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>presence of emesis- dichotomous variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Opioid Effect: Pruritus</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>presence of pruritus- dichotomous variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Opioid Effect: Respiratory Depression</measure>
    <time_frame>every 4 hours up to 48 hours</time_frame>
    <description>presence of respiratory depression- dichotomous variable</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Pain Management</condition>
  <condition>Spinal Fusion</condition>
  <condition>Scoliosis</condition>
  <arm_group>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receives a single dose of intrathecal morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extended Release Epidural Morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives DepoDur extended release epidural morphine for pain management</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal morphine</intervention_name>
    <description>Morphine injection is a systemic narcotic analgesic for administration by the intravenous, epidural or intrathecal routes. It is used for the management of pain.</description>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <other_name>IT Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended Release Epidural Morphine</intervention_name>
    <description>DepoDurâ„¢ is a preparation of extended release lipid encapsulated morphine and is used specifically for epidural injection, outside the spinal fluid, for postoperative pain. This study is a prospective randomized double-blinded trial examining the effectiveness of single dose intrathecal morphine versus single dose extended release epidural morphine for postoperative pain control in pediatric posterior spinal fusion patients.</description>
    <arm_group_label>Extended Release Epidural Morphine</arm_group_label>
    <other_name>EREM</other_name>
    <other_name>DepoDur</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and females, 8 to17 years old undergoing posterior spinal fusion for idiopathic
             scoliosis.

          2. Fusion of a minimum of 5, and a maximum of 13 levels, including at least L1 or lower.

        Exclusion Criteria:

          1. Neuromuscular scoliosis.

          2. A history of documented coagulopathy or platelet count of less than 100,000 mm3.

          3. A known allergy or adverse sensitivity to morphine.

          4. Pulmonary hypertension or other significant respiratory problem.

          5. Cognitive deficits that would impair use of PCA and/or filling out questionnaire.

          6. History of sleep apnea defined by sleep study and/or need for nighttime CPAP.

          7. Abnormal pain thresholds (i.e., subjects who are on significant opioids
             preoperatively).

          8. Baseline neurologic deficits (numbness, motor deficits, or any focal neurological
             sign).

          9. Subjects who are anticipated to remain intubated postoperatively for longer than 2
             hours.

         10. Need for preoperative intravenous inotropic drugs.

         11. Significant metabolic, endocrine or neuropathology, cyanosis, or renal insufficiency.

         12. A contraindication to dural puncture, such as raised intracranial pressure.

         13. Pre-operative heparin, oral aspirin or anticoagulants.

         14. Weight less than 20kg or greater than 100kg.

         15. Need for Intraoperative ketamine administration.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mindy Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Children's Hospital- Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 10, 2009</study_first_submitted>
  <study_first_submitted_qc>April 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2009</study_first_posted>
  <results_first_submitted>May 1, 2017</results_first_submitted>
  <results_first_submitted_qc>April 21, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 22, 2020</results_first_posted>
  <last_update_submitted>April 21, 2020</last_update_submitted>
  <last_update_submitted_qc>April 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Pediatric</keyword>
  <keyword>Spinal Fusion</keyword>
  <keyword>pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>84 patients consented to participate. 3 patients did not start the study due to physician discretion.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Intrathecal Morphine</title>
          <description>Receives a single dose of intrathecal morphine
Intrathecal morphine: Morphine injection is a systemic narcotic analgesic for administration by the intravenous, epidural or intrathecal routes. It is used for the management of pain.</description>
        </group>
        <group group_id="P2">
          <title>DepoDur</title>
          <description>Receives DepoDur extended release morphine for pain management
DepoDur: DepoDurâ„¢ is a preparation of extended release lipid encapsulated morphine and is used specifically for epidural injection, outside the spinal fluid, for postoperative pain. This study is a prospective randomized double-blinded trial examining the effectiveness of single dose intrathecal morphine versus single dose extended release epidural morphine for postoperative pain control in pediatric posterior spinal fusion patients.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Observation After Receiving Medication</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>surgery did not extend past L1 level</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intrathecal Morphine</title>
          <description>Receives a single dose of intrathecal morphine
Intrathecal morphine: Morphine injection is a systemic narcotic analgesic for administration by the intravenous, epidural or intrathecal routes. It is used for the management of pain.</description>
        </group>
        <group group_id="B2">
          <title>DepoDur</title>
          <description>Receives DepoDur extended release morphine for pain management
DepoDur: DepoDurâ„¢ is a preparation of extended release lipid encapsulated morphine and is used specifically for epidural injection, outside the spinal fluid, for postoperative pain. This study is a prospective randomized double-blinded trial examining the effectiveness of single dose intrathecal morphine versus single dose extended release epidural morphine for postoperative pain control in pediatric posterior spinal fusion patients.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="71"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.8" spread="1.9"/>
                    <measurement group_id="B2" value="14.2" spread="1.9"/>
                    <measurement group_id="B3" value="14.0" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.6" spread="12.0"/>
                    <measurement group_id="B2" value="55.2" spread="10.44"/>
                    <measurement group_id="B3" value="54.4" spread="11.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total IV Morphine Consumption up to 48 Hours Post Surgery</title>
        <description>Total IV morphine consumption during the first 0- 48 hours after surgery.Postoperative pain was treated with morphine PCA, ketorolac, oral oxycodone, and acetaminophen.</description>
        <time_frame>Four hour intervals for up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>single dose of intrathecal morphine
Intrathecal morphine: Morphine injection is a systemic narcotic analgesic for administration by the intravenous, epidural or intrathecal routes. It is used for the management of pain.</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>Receives extended release epidural morphine for pain management
DepoDur: DepoDurâ„¢ is a preparation of extended release lipid encapsulated morphine and is used specifically for epidural injection, outside the spinal fluid, for postoperative pain. This study is a prospective randomized double-blinded trial examining the effectiveness of single dose intrathecal morphine versus single dose extended release epidural morphine for postoperative pain control in pediatric posterior spinal fusion patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Total IV Morphine Consumption up to 48 Hours Post Surgery</title>
          <description>Total IV morphine consumption during the first 0- 48 hours after surgery.Postoperative pain was treated with morphine PCA, ketorolac, oral oxycodone, and acetaminophen.</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>mg</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.0" lower_limit="4.5" upper_limit="128.8"/>
                    <measurement group_id="O2" value="42.2" lower_limit="5.5" upper_limit="123.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Wilcoxon rank-sum test because the outcome variable was found to have a skewed distribution.</non_inferiority_desc>
            <p_value>.27</p_value>
            <p_value_desc>Hodges-Lehmanne estimation method</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>7.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.8</ci_lower_limit>
            <ci_upper_limit>21.2</ci_upper_limit>
            <estimate_desc>Hodges-Lehmanne estimation method</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Until First PCA Demand Request</title>
        <description>At 4-hour intervals for up to 48 hours IV PCA demands.</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until First PCA Demand Request</title>
          <description>At 4-hour intervals for up to 48 hours IV PCA demands.</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.99" lower_limit="0.7500" upper_limit="1.1500"/>
                    <measurement group_id="O2" value="0.92" lower_limit="0.5833" upper_limit="1.4333"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Log-rank test in Kaplan-Meier used.</non_inferiority_desc>
            <p_value>.42</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Pain Scores</title>
        <description>Post-operative pain scores using Bieri faces scale every 4 hours up to 48 hours. Using Bieri faces pain scale. The faces show how much something can hurt. The &quot;happy face&quot; with a smile is no pain = 0 to faces showing more and more pain up 10. The space between two faces is scored 1, 3,5,7, or 9. to 10 (worst pain) will be used every 4 hours post-op for up to 48 hours.
*Scores were not collected and/or included for all participants at all time points. If a patient was sleeping, there score was not recorded. If a patient completed the pain scale incorrectly (used an even number or included a range), then the data point was not included.</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Pain Scores</title>
          <description>Post-operative pain scores using Bieri faces scale every 4 hours up to 48 hours. Using Bieri faces pain scale. The faces show how much something can hurt. The &quot;happy face&quot; with a smile is no pain = 0 to faces showing more and more pain up 10. The space between two faces is scored 1, 3,5,7, or 9. to 10 (worst pain) will be used every 4 hours post-op for up to 48 hours.
*Scores were not collected and/or included for all participants at all time points. If a patient was sleeping, there score was not recorded. If a patient completed the pain scale incorrectly (used an even number or included a range), then the data point was not included.</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.26" spread="0.53"/>
                    <measurement group_id="O2" value="6.69" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.70" spread="0.38"/>
                    <measurement group_id="O2" value="4.03" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="0.36"/>
                    <measurement group_id="O2" value="2.88" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="27"/>
                    <count group_id="O2" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.96" spread="0.37"/>
                    <measurement group_id="O2" value="2.19" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.13" spread="0.45"/>
                    <measurement group_id="O2" value="3.03" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.61" spread="0.35"/>
                    <measurement group_id="O2" value="2.80" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.10" spread="0.40"/>
                    <measurement group_id="O2" value="3.17" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>32 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.83" spread="0.45"/>
                    <measurement group_id="O2" value="2.81" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="27"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.85" spread="0.57"/>
                    <measurement group_id="O2" value="2.86" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.92" spread="0.48"/>
                    <measurement group_id="O2" value="3.09" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>44 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.63" spread="0.42"/>
                    <measurement group_id="O2" value="3.10" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" spread="0.37"/>
                    <measurement group_id="O2" value="3.77" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Opioid Effect: Nausea</title>
        <description>presence of nausea- dichotomous variable</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Opioid Effect: Nausea</title>
          <description>presence of nausea- dichotomous variable</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>percentage of patients with nausea</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Opioid Effect: Emesis</title>
        <description>presence of emesis- dichotomous variable</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Opioid Effect: Emesis</title>
          <description>presence of emesis- dichotomous variable</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>percentage of patients with emesis</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.30</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Opioid Effect: Pruritus</title>
        <description>presence of pruritus- dichotomous variable</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Opioid Effect: Pruritus</title>
          <description>presence of pruritus- dichotomous variable</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>percentage of patients with pruritus</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Opioid Effect: Respiratory Depression</title>
        <description>presence of respiratory depression- dichotomous variable</description>
        <time_frame>every 4 hours up to 48 hours</time_frame>
        <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
        <group_list>
          <group group_id="O1">
            <title>Intrathecal Morphine</title>
            <description>Intrathecal morphine
Receives a single dose of intrathecal morphine</description>
          </group>
          <group group_id="O2">
            <title>EREM</title>
            <description>extended-release epidural morphine is marketed as DepoDurTM which is a preservative-free sterile suspension of multivesicular liposomes (DepoFoamÂ®) containing morphine, intended for epidural administration. DepoFoam consists of lipid-based particles containing discrete water-filled chambers dispersed through the lipid matrix. The lipids are naturally occurring substances such as phospholipids and triglycerides. The small amount of lipid is cleared rapidly in the body as the particles deliver their drug payload</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Opioid Effect: Respiratory Depression</title>
          <description>presence of respiratory depression- dichotomous variable</description>
          <population>Intent to treat pediatric patients between 8-17 years of age undergoing thoracolumbar posterior spinal fusion with either Intrathecal morphine versus extended-release epidural morphine for post operative pain control.</population>
          <units>% patients with respiratory depression</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.31</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Immediately Post Op to 48 hours after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intrathecal Morphine</title>
          <description>Receives a single dose of intrathecal morphine
Intrathecal morphine: Morphine injection is a systemic narcotic analgesic for administration by the intravenous, epidural or intrathecal routes. It is used for the management of pain.</description>
        </group>
        <group group_id="E2">
          <title>DepoDur</title>
          <description>Receives DepoDur extended release morphine for pain management
DepoDur: DepoDurâ„¢ is a preparation of extended release lipid encapsulated morphine and is used specifically for epidural injection, outside the spinal fluid, for postoperative pain. This study is a prospective randomized double-blinded trial examining the effectiveness of single dose intrathecal morphine versus single dose extended release epidural morphine for postoperative pain control in pediatric posterior spinal fusion patients.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology</name_or_title>
      <organization>Children's Hospital of Colorado, University of Colorado</organization>
      <email>Mindy.cohen@childrenscolorado.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

